Search
-
Weight loss drug hope for patients with type 2 diabetes
https://le.ac.uk/news/2021/march/weight-loss-drug-hope
Patients with type 2 diabetes that were treated with a weekly injection of the breakthrough drug Semaglutide were able to achieve an average weight loss of nearly 10kg, according to a new study published in The Lancet today.
-
Blood clots during COVID-19 may be a cause of ongoing cognitive problems
https://le.ac.uk/news/2023/september/brain-fog
High levels of two proteins at the time of COVID-19 have been found in patients who later experienced cognitive problems, including ‘brain fog’, giving a major clue as to one cause of their symptoms: blood clots
-
2023 Statistics
https://le.ac.uk/dbs/legislative-responsibilities/species-statistics/2023
2023 RoPs
-
Publications
https://le.ac.uk/biostatistics/publications
Explore the publications related to Biostatistics research at the University of Leicester.
-
Digitally General: why digital is not always the answer
https://staffblogs.le.ac.uk/lli/2018/10/12/digitally-general-why-digital-is-not-always-the-answer/
Posted by bcox in Leicester Learning Institute: Enhancing learning and teaching on October 12, 2018 Making something digital does not always make it better. Why? It not the digital itself that it actually the issue.
-
Your Career and Other Stories
https://le.ac.uk/modules/2024/en2290
Module code: EN2290
-
Your Career and Other Stories
https://le.ac.uk/modules/2025/en2290
Module code: EN2290
-
Your Career and Other Stories
https://le.ac.uk/modules/2026/en2290
Module code: EN2290
-
What our students say
https://le.ac.uk/cite/eltu/presessional/why-leicester/our-students
Hear more from students who have studied with us in the ELTU on the Presessional English Programme at Leicester.
-
Chemotherapy-free treatment gives hope to adult leukaemia patients
https://le.ac.uk/news/2019/april/25-chemotherapy-free-leukaemia-treatment
Patients with chronic lymphocytic leukaemia (CLL) may be offered a chemotherapy-free treatment in future, following promising results from a global study involving researchers in the Hope Clinical Trials Facility at Leicester’s Hospitals and the University of Leicester.